An increasing number of lawsuits involving Zofran-related birth defects have been filed across the nation. One of the latest claims was brought by an Oregon mother who argues that her child’s cleft palate and laryngeal cleft are a direct result of the anti-nausea drug she took while pregnant. GlaxoSmithKline LLC... Read more »

Attorneys for GlaxoSmithKline (GSK) have petitioned that Zofran lawsuits involving birth defects filed against the company be dismissed by the federal judge overseeing litigation. The move comes relatively early in the course of a multidistrict litigation (MDL 2657) set up to process the increasing number of lawsuits filed over birth defects... Read more »

GlaxoSmithKline (GSK) is engaging in wrongful conduct by failing to adequately disclose the risks of Zofran when used by women who are pregnant, according to a new birth defect lawsuit filed by a mother from Tennessee. The lawsuit is pending in the U.S. District Court for the Eastern District of... Read more »

A 20-year-old woman has filed a Zofran lawsuit in California. The case seeks to hold defendants GlaxoSmithKline and McKesson Corporation responsible for the birth defects that the plaintiff suffered after her mother took Zofran during pregnancy. The Texas woman filed her complaint in the United States District Court for the Northern District of... Read more »

For many women, the hormonal fluctuations associated with pregnancy bring about unrelenting symptoms including nausea, vomiting and lightheadedness. In the most extreme cases, these women experience a condition known as hyperemesis gravidarum – which can cause dehydration and electrolyte imbalance. For years, doctors and healthcare professionals have prescribed a drug... Read more »

A Louisiana mother has filed a Zofran lawsuit against GlaxoSmithKline on behalf of her son. Zofran (ondansetron) is a prescription medication used to prevent nausea and vomiting in chemotherapy or radiation patients. It is also commonly used by pregnant women suffering from morning sickness, though it has not received approval... Read more »

The U.S. Judicial Panel on Multidistrict Litigation (JPML) issued a transfer order on October 13, 2015 to centralize all federal Zofran claims into a multidistrict litigation (MDL). The MDL is pending in the U.S. District Court for the District of Massachusetts, where it is proceeding under the direction of Judge F.... Read more »

A Kentucky couple has filed a Zofran lawsuit against manufacturer GlaxoSmithKline, LLC (GSK) over the death of their son. The lawsuit also names Hospira, Inc., and Pfizer, Inc., makers of the generic form of the drug, as defendants. The lawsuit was filed on September 30, 2015, in the United States... Read more »

Drug maker GlaxoSmithKline (GSK) is named defendant in a Zofran lawsuit alleging the drug carries a disproportionate risk of causing congenital birth defects when taken by pregnant women. The complaint was filed by a minor plaintiff and her parents in the United States District Court for the Northern District of... Read more »

Off-label use of prescription medications, a common practice that healthcare providers have long relied on and that pharmaceutical companies have profited from, has become the subject of a great deal of controversy. Billions in settlements have been paid out to patients who were allegedly harmed as a result of the off-label... Read more »